Now accepting Telehealth appointments. Schedule a virtual visit.

Study Supports the Use of Repetitive TMS for Treatment Resistant Depression

Major depressive disorder is one of the top cause of disability around the world. Despite the many forms of treatment, there are many patient still resistant to these treatment options. Repetitive transcranial magnetic stimulation is a treatment option without the side effects of pharmacological options and electroconvulsive therapy (ECT). TMS has been approved by the FDA as a treatment for treatment resistant depression since 2008. 

This study was the largest naturalistic study with clinician rated scales by psychiatrists and demonstrated that patients demonstrated greater improvements following rTMS. In this study, they found that pateints with severe depression had greater improvements according to the MADRS questionaire while those with milder depression at baseline were more likely to achieve remission. They concluded that TMS should be used as a first-line treatment for moderate to severe depression. Please give us a call if you would like more information. 

Read the published article here.

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).